Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Asset Utilization Ratio (2025)

Historic Asset Utilization Ratio for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 0.26.

  • Day One Biopharmaceuticals' Asset Utilization Ratio rose 2710.33% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year increase of 2710.33%. This contributed to the annual value of 0.27 for FY2024, which is N/A changed from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.26 for Q3 2025, which was up 2710.33% from 0.36 recorded in Q2 2025.
  • Day One Biopharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.36 during Q2 2025, with a 5-year trough of 0.02 in Q2 2024.